Delayed achievement of cytogenetic and molecular response is associated with increased risk of progression among patients with chronic myeloid leukemia in early chronic phase receiving high-dose or standard-dose imatinib therapy

Patients not in complete cytogenetic response (CCyR) continuously face the competing possibilities of eventually achieving a cytogenetic response versus progressing. We analyzed the probability of achieving a CCyR, major molecular response, and progression in 258 patients with chronic myeloid leukem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Quintás-Cardama, Alfonso, Kantarjian, Hagop, Jones, Dan, Shan, Jianqin, Borthakur, Gautam, Thomas, Deborah, Kornblau, Steven, O'Brien, Susan, Cortes, Jorge
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2009
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3953080/
https://ncbi.nlm.nih.gov/pubmed/19369233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-07-166694
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados